Filing Details

Accession Number:
0001209191-11-030183
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-05-20 18:42:09
Reporting Period:
2011-05-18
Filing Date:
2011-05-20
Accepted Time:
2011-05-20 18:42:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1087432 Intermune Inc ITMN Pharmaceutical Preparations (2834) 943296648
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1303832 Allan Howard Simon 3280 Bayshore Boulevard
Brisbane CA 94005
Svp-Human Resources No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-05-18 70,000 $14.71 113,795 No 4 M Direct
Common Stock Acquisiton 2011-05-18 8,125 $12.74 121,920 No 4 M Direct
Common Stock Acquisiton 2011-05-18 26,250 $15.40 148,170 No 4 M Direct
Common Stock Acquisiton 2011-05-18 1,848 $25.50 150,018 No 4 M Direct
Common Stock Disposition 2011-05-18 109,656 $38.78 40,362 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2011-05-18 70,000 $0.00 70,000 $14.71
Common Stock Stock Option (Right to Buy) Disposition 2011-05-18 8,125 $0.00 8,125 $12.74
Common Stock Stock Option (Right to Buy) Disposition 2011-05-18 26,250 $0.00 26,250 $15.40
Common Stock Stock Option (Right to Buy) Disposition 2011-05-18 1,848 $0.00 1,848 $25.50
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2014-05-03 No 4 M Direct
0 2015-06-24 No 4 M Direct
0 2016-06-30 No 4 M Direct
9,652 2017-05-15 No 4 M Direct
Footnotes
  1. Represents the weighted average sale price for the entire number of shares sold. The sale prices range from $38.75 to $38.94 per share. Full information on the numbers of shares sold at each sale price is available upon request.
  2. Fully Exercisable.